Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Neoplasms 1Chronic Pain 1

Interventions

Water 3Psychiatric Rehabilitation 3Colonoscopy 3Analgesia 3Therapeutics 2Radiotherapy 2Ibandronic Acid 2resiniferatoxin 1Zoledronic Acid 1Transcranial Direct Current Stimulation 1Surveys and Questionnaires 1Sufentanil 1Standard of Care 1Radiation 1Quality of Life 1Psilocybin 1Palliative Care 1Pain Management 1Olanzapine 1Nutritional Support 1Nicotine 1Lidocaine 1Interviews as Topic 1Genistein 1Fentanyl 1Cryotherapy 1Cryosurgery 1Celecoxib 1Botulinum Toxins, Type A 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Pain × Sufentanil × Clear all
NCT00943566 2015-09-15

A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer

Labtec GmbH

Phase 2 Withdrawn

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡